← Open Payments lookup

MIKHAIL ALPER: Open Payments

NPI 1588698112 · MADERA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$286,377 in 786 payments from 24 companies in 2025. Trend: 2023 $183,337 · 2024 $265,602 · 2025 $286,377

Speaker / faculty: $211,981Travel & lodging: $40,997Food & beverage: $17,639Consulting: $12,430Honoraria: $3,200Education: $130
CompanyPaymentsAmount
Janssen Biotech, Inc.124$77,600
ABBVIE INC.135$41,799
Aimmune Therapeutics, Inc.77$27,489
Madrigal Pharmaceuticals66$24,852
Gilead Sciences, Inc.51$23,083
Regeneron Healthcare Solutions, Inc.42$21,723
Lilly USA, LLC23$15,687
GENZYME CORPORATION20$14,689
Ipsen Biopharmaceuticals, Inc32$11,526
Salix Pharmaceuticals, a division of Bausch Health US, LLC99$6,922

Products named: TREMFYA, ZENPEP, REZDIFFRA, Livdelzi, CREON, DUPIXENT, OMVOH, IQIRVO.

Industry payments across CA — which companies pay providers there.